Founded in March 2023, Moonshot AI is among the better-known startups developing generative artificial intelligence in China, hoping to eventually match the likes of OpenAI and Google.
Krutrim, dedicated to constructing the entire AI computing stack, announced the success of its funding round and outlined ambitious plans for the future.
AstraZeneca taps into AI firms to build cancer antibodies to replace chemotherapy.
. Generative AI-Built Cancer Antibodies will reportedly be worked on by AstraZeneca and Absci after signing a deal approximately worth $247 million, as reported by Reuters.
The AI economy is freely operating because of the availability of data for training. However, it's not as infinite as what we imagine as data wells might run dry someday.